Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
GLP-1 receptor agonists (RAs) were originally developed to treat type 2 diabetes mellitus (T2DM) and have been FDA-approved for this indication since 2005
GLP-1s may reduce the production of pro-inflammatory adipokines, thereby reducing inflammation in individuals with obesity or metabolic syndrome
Prepare ahead: Keep your medication and supplies in one designated, easy-to-access spot
When a urine sample contains a substance above a predetermined threshold concentration, the antibodies in the test bind to that substance, triggering a detectable signal
Medical disclaimer: This article is for general education and does not replace care from a licensed clinician
Additional studies have also shown that patients taking GLP-1 receptor agonists also have significantly lower rates of kidney outcomes such as macroalbuminuria or progression to end-stage kidney disease
US$ 27.43
US$ 28.40
US$ 28.58
US$ 26.76
US$ 26.74
US$ 24.81
US$ 26.39
US$ 24.95
US$ 29.81
US$ 28.46
